277 related articles for article (PubMed ID: 20859201)
21. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
Crameri R
Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
[TBL] [Abstract][Full Text] [Related]
22. Peptide and recombinant immunotherapy.
Larché M
Immunol Allergy Clin North Am; 2011 May; 31(2):377-89, xi. PubMed ID: 21530826
[TBL] [Abstract][Full Text] [Related]
23. Improving pollen immunotherapy: minor allergens and panallergens.
Moreno-Aguilar C
Allergol Immunopathol (Madr); 2008; 36(1):26-30. PubMed ID: 18261430
[TBL] [Abstract][Full Text] [Related]
24. Recombinant allergens for pollen immunotherapy.
Wallner M; Pichler U; Ferreira F
Immunotherapy; 2013 Dec; 5(12):1323-38. PubMed ID: 24283843
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
[TBL] [Abstract][Full Text] [Related]
26. Molecular composition and biological activity of commercial birch pollen allergen extracts.
Focke M; Marth K; Valenta R
Eur J Clin Invest; 2009 May; 39(5):429-36. PubMed ID: 19302561
[TBL] [Abstract][Full Text] [Related]
27. [Allergen-specific immunotherapy or desensitization].
Demoly P; Michel FB
Bull Acad Natl Med; 2009 May; 193(5):1127-44; discussion 1144-5. PubMed ID: 20120392
[TBL] [Abstract][Full Text] [Related]
28. Designing hypoallergenic derivatives for allergy treatment by means of in silico mutation and screening.
Thalhamer T; Dobias H; Stepanoska T; Pröll M; Stutz H; Dissertori O; Lackner P; Ferreira F; Wallner M; Thalhamer J; Hartl A
J Allergy Clin Immunol; 2010 Apr; 125(4):926-934.e10. PubMed ID: 20371399
[TBL] [Abstract][Full Text] [Related]
29. Molecular design of allergy vaccines.
Linhart B; Valenta R
Curr Opin Immunol; 2005 Dec; 17(6):646-55. PubMed ID: 16229996
[TBL] [Abstract][Full Text] [Related]
30. [Interests of recombinant allergens in the practice of allergy].
Karoui O; Leimgruber A; Spertini F
Rev Med Suisse; 2013 Jan; 9(368):22-7. PubMed ID: 23367699
[TBL] [Abstract][Full Text] [Related]
31. Strategies for recombinant allergen vaccines and fruitful results from first clinical studies.
Cromwell O; Fiebig H; Suck R; Kahlert H; Nandy A; Kettner J; Narkus A
Immunol Allergy Clin North Am; 2006 May; 26(2):261-81, vii. PubMed ID: 16701144
[TBL] [Abstract][Full Text] [Related]
32. The future of sublingual immunotherapy.
Marcucci F; Duse M; Frati F; Incorvaia C; Marseglia GL; La Rosa M
Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):31-3. PubMed ID: 19944008
[TBL] [Abstract][Full Text] [Related]
33. Clinical evaluation of recombinant allergens.
Cromwell O; Narkus A
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):195-200; discussion 200-3. PubMed ID: 17393740
[No Abstract] [Full Text] [Related]
34. Future forms of immunotherapy.
Casale TB; Stokes JR
J Allergy Clin Immunol; 2011 Jan; 127(1):8-15; quiz 16-7. PubMed ID: 21094518
[TBL] [Abstract][Full Text] [Related]
35. Genetic engineering of recombinant hypoallergenic oligomers of the major birch pollen allergen, Bet v 1: candidates for specific immunotherapy.
Vrtala S; Hirtenlehner K; Susani M; Hufnagl P; Binder BR; Vangelista L; Pastore A; Sperr WR; Valent P; Ebner C; Kraft D; Valenta R
Int Arch Allergy Immunol; 1999; 118(2-4):218-9. PubMed ID: 10224386
[No Abstract] [Full Text] [Related]
36. [Diagnostic and therapeutic value of synthetic or recombinant allergens].
Spertini F
Rev Med Suisse Romande; 1999 Mar; 119(3):235-9. PubMed ID: 10218421
[TBL] [Abstract][Full Text] [Related]
37. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
Focke M; Swoboda I; Marth K; Valenta R
Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
[TBL] [Abstract][Full Text] [Related]
38. Recombinant allergens: what does the future hold?
Valenta R; Niespodziana K; Focke-Tejkl M; Marth K; Huber H; Neubauer A; Niederberger V
J Allergy Clin Immunol; 2011 Apr; 127(4):860-4. PubMed ID: 21458656
[TBL] [Abstract][Full Text] [Related]
39. Recombinant allergens for diagnosis and therapy of allergic disease.
Chapman MD; Smith AM; Vailes LD; Arruda LK; Dhanaraj V; Pomés A
J Allergy Clin Immunol; 2000 Sep; 106(3):409-18. PubMed ID: 10984358
[TBL] [Abstract][Full Text] [Related]
40. Allergen immunotherapy: a history of the first 100 years.
Fitzhugh DJ; Lockey RF
Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):554-9. PubMed ID: 21971334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
